Skip to main content

Cryptospike CVE-2023-36646

HIGH
Incorrect Authorization (CWE-863)
2023-12-12 cve@mitre.org
8.8
CVSS 3.1 · NVD
Share

Severity by source

NVD PRIMARY
8.8 HIGH
AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
Network
Attack Complexity
Low
Privileges Required
Low
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
High

Lifecycle Timeline

1
CVE Published
Dec 12, 2023 - 00:15 nvd
HIGH 8.8

DescriptionNVD

Incorrect user role checking in multiple REST API endpoints in ProLion CryptoSpike 3.0.15P2 allows a remote attacker with low privileges to execute privileged functions and achieve privilege escalation via REST API endpoint invocation.

AnalysisAI

Incorrect user role checking in multiple REST API endpoints in ProLion CryptoSpike 3.0.15P2 allows a remote attacker with low privileges to execute privileged functions and achieve privilege. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Incorrect Authorization (CWE-863), which allows attackers to bypass authorization checks to access restricted resources. Incorrect user role checking in multiple REST API endpoints in ProLion CryptoSpike 3.0.15P2 allows a remote attacker with low privileges to execute privileged functions and achieve privilege escalation via REST API endpoint invocation. Affected products include: Prolion Cryptospike.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Review and test authorization logic, implement consistent access control checks, use centralized authorization framework.

Share

CVE-2023-36646 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy